Atlas FDA

Access AFP Reagents on the Access Immunoassay Systems

FDA premarket approval P980041/S040 · decided 2018-09-12

Approval details

PMA number
P980041
Supplement
S040
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Access AFP Reagents on the Access Immunoassay Systems
Generic name
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Applicant
Beckman Coulter, Inc.
Date received
2018-08-13
Decision date
2018-09-12
Days to decision
30 days
Decision code
OK30
Product code
LOK
Advisory committee
Immunology
Expedited review
No
Location
Brea, CA
Statement
Manufacturing change (cell culture) to the AFP reagent antibody production process for increased productivity (batch size) and improved capacity.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Access BNP II (K252169)Beckman Coulter, Inc.2026-03-24
Access anti-HBc IgM (K254059)Beckman Coulter, Inc.2026-03-13
Access anti-HBc Total (K253687)Beckman Coulter, Inc.2026-02-19
Access anti-HAV IgM (K251995)Beckman Coulter, Inc.2026-01-27
Access Rubella IgG (K250588)Beckman Coulter, Inc.2025-11-17
iQ200 Series (K252580)Beckman Coulter, Inc.2025-09-10
Access anti-HAV (K243846)Beckman Coulter, Inc.2025-09-09
MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804)Beckman Coulter, Inc.2025-08-20